Business Description
Brawn Biotech Ltd
ISIN : INE899B01015
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.49 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.37 | |||||
Beneish M-Score | -1.31 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -25.3 | |||||
3-Year Book Growth Rate | -12 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 79.29 | |||||
9-Day RSI | 77.79 | |||||
14-Day RSI | 73.12 | |||||
6-1 Month Momentum % | 0.83 | |||||
12-1 Month Momentum % | 10.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.05 | |||||
Quick Ratio | 1.37 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 104.34 | |||||
Days Sales Outstanding | 102.67 | |||||
Days Payable | 140.95 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 5.21 | |||||
Operating Margin % | -8.43 | |||||
Net Margin % | -11.15 | |||||
FCF Margin % | 1.37 | |||||
ROE % | -28.6 | |||||
ROA % | -13.58 | |||||
ROIC % | -31.35 | |||||
ROC (Joel Greenblatt) % | -29.51 | |||||
ROCE % | -20.65 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 28.84 | |||||
PS Ratio | 0.48 | |||||
PB Ratio | 1.38 | |||||
Price-to-Tangible-Book | 1.38 | |||||
Price-to-Free-Cash-Flow | 35.32 | |||||
Price-to-Operating-Cash-Flow | 24.69 | |||||
EV-to-EBIT | -4.65 | |||||
EV-to-EBITDA | -5.04 | |||||
EV-to-Revenue | 0.39 | |||||
EV-to-FCF | 28.5 | |||||
Price-to-Median-PS-Value | 2.08 | |||||
Earnings Yield (Greenblatt) % | -21.51 | |||||
FCF Yield % | 2.83 | |||||
Forward Rate of Return (Yacktman) % | 9.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Brawn Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 162.439 | ||
EPS (TTM) (₹) | -6.039 | ||
Beta | 0.89 | ||
Volatility % | 63.95 | ||
14-Day RSI | 73.12 | ||
14-Day ATR (₹) | 0.731401 | ||
20-Day SMA (₹) | 22.025 | ||
12-1 Month Momentum % | 10.81 | ||
52-Week Range (₹) | 14.36 - 27.37 | ||
Shares Outstanding (Mil) | 3 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Brawn Biotech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Brawn Biotech Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Brawn Biotech Ltd Frequently Asked Questions
What is Brawn Biotech Ltd(BOM:530207)'s stock price today?
When is next earnings date of Brawn Biotech Ltd(BOM:530207)?
Does Brawn Biotech Ltd(BOM:530207) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |